Hello, everyone, and nice to see you again. We are happy to report that we have returned in one piece from an extended round of schmoozing and kibbitzing in the swamp, where we encountered a delightful mix of old and new contacts. We thank them for their time. Now, though, we must return to the usual routine, which of course, includes a few cups of stimulation — our choice today is milk chocolate caramel, seriously. Meanwhile, here are your tidbits. Have a smashing day and do keep us in mind when you run across secret dossiers …

Astellas Pharma is the latest drug maker to reveal it is a subject of a U.S. probe into pharmaceutical industry support of charities offering assistance to Medicare patients seeking help to cover out-of-pocket drug costs, Reuters reports. In a lawsuit filed against its insurers, the drug maker disclosed that the U.S. Justice Department was conducting a joint criminal and civil investigation.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy